Progyny Inc (PGNY) is expecting -39.69% growth in the next quarter: What can investors do to maximize their returns?

On Tuesday, Progyny Inc (NASDAQ: PGNY) opened lower -1.01% from the last session, before settling in for the closing price of $14.89. Price fluctuations for PGNY have ranged from $13.39 to $42.08 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

During the last 5-year period, the sales growth of Healthcare Sector giant was 61.75%. Company’s average yearly earnings per share was noted -13.23% at the time writing. With a float of $71.52 million, this company’s outstanding shares have now reached $88.34 million.

Let’s determine the extent of company efficiency that accounts for 566 employees. In terms of profitability, gross margin is 21.68%, operating margin of 5.75%, and the pretax margin is 7.18%.

Progyny Inc (PGNY) Insider Activity

A key investor’s attitude towards the stock of the Health Information Services industry is another important factor to consider. The insider ownership of Progyny Inc is 16.01%, while institutional ownership is 90.52%. The most recent insider transaction that took place on Dec 09 ’24, was worth 627,648. Before that another transaction happened on Jul 16 ’24, when Company’s PRESIDENT sold 9,030 for $30.00, making the entire transaction worth $270,900. This insider now owns 362,583 shares in total.

Progyny Inc (PGNY) Earnings and Forecasts

According to the Wall Street analysts, stocks earnings will be around -13.23% per share during the next fiscal year.

Progyny Inc (NASDAQ: PGNY) Trading Performance Indicators

Check out the current performance indicators for Progyny Inc (PGNY). In the past quarter, the stock posted a quick ratio of 2.62. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.10. Likewise, its price to free cash flow for the trailing twelve months is 7.82.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.58, a number that is poised to hit 0.09 in the next quarter and is forecasted to reach 0.59 in one year’s time.

Technical Analysis of Progyny Inc (PGNY)

Looking closely at Progyny Inc (NASDAQ: PGNY), its last 5-days average volume was 1.47 million, which is a jump from its year-to-date volume of 1.4 million. As of the previous 9 days, the stock’s Stochastic %D was 23.29%. Additionally, its Average True Range was 0.65.

During the past 100 days, Progyny Inc’s (PGNY) raw stochastic average was set at 8.30%, which indicates a significant decrease from 22.89% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 43.18% in the past 14 days, which was lower than the 86.61% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $15.49, while its 200-day Moving Average is $24.70. However, in the short run, Progyny Inc’s stock first resistance to watch stands at $15.13. Second resistance stands at $15.53. The third major resistance level sits at $15.76. If the price goes on to break the first support level at $14.51, it is likely to go to the next support level at $14.28. Should the price break the second support level, the third support level stands at $13.89.

Progyny Inc (NASDAQ: PGNY) Key Stats

There are currently 85,153K shares outstanding in the company with a market cap of 1.26 billion. Presently, the company’s annual sales total 1,089 M according to its annual income of 62,040 K. Last quarter, the company’s sales amounted to 286,630 K and its income totaled 10,420 K.